A study of the factors influencing tuberculosis treatment outcomes in HIV-TB co-infected patients in an urban district of South India  by Mohan, A. et al.
l of In
T
F
S
D
T
R
A
c
S
A
l
i
a
f
s
g
N
i
p
i
o
o
a
u
A
i
i
s
w
3
M
c
c
i
T
(
t
0
(
t
i
w
c
h
Conclusion:Nested IS6110 PCR increased the accuracy of histo-15th ICID Abstracts / International Journa
ype: Poster Presentation
inal Abstract Number: 47.024
ession: Tuberculosis & Other Mycobacterial Infections
ate: Friday, June 15, 2012
ime: 12:45-14:15
oom: Poster & Exhibition Area
study of the factors inﬂuencing tuberculosis treatment out-
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BANGALORE MEDICAL COLLEGE AND RESEARCH INSTITUTE, Banga-
ore, Karnataka, India
Background: The outcome of tuberculosis (TB) treatment is
nﬂuenced by Human Immunodeﬁciency Virus (HIV) infection,
nd is known to be less successful when compared to HIV unin-
ected. A clear picture of the treatment-outcomes with the current
trategies in India i.e. Revised National Tuberculosis Control Pro-
ram(RNTCP)’s Directly observed treatment short course(DOTS) &
ational AIDS Control Program(NACP)’s ART, & the factors that
nﬂuence such outcomes could prove useful in improving existing
rograms.
Methods: Objectives: To know the type of TB among HIV
nfected patients. To study the factors that inﬂuence TB treatment
utcome.
Study design: A longitudinal study.
Study area: Bruhat Bengaluru Mahanagara Palike (BBMP) area
f Bangalore.
Study population: Adults diagnosed with TB & HIV infections,
nd registered in RNTCP for DOTS.
Study duration: November 2010 to January 2012.
Sampling method: Cluster sampling. 4 of the 9 Tuberculosis
nits (TU), in Bangalore were chosen by simple random sampling.
ll subjects in the selected TU’swhomet the inclusion criteriawere
ncluded following their consent.
Studymethod: Apersonal interviewof the subjects at scheduled
ntervals through-out the course of treatment using a pre-tested &
emi-structured questionnaire at their DOTS centres.
Data analysis: Data is presented as percentages. Chi-square test
as used where appropriate.
Results: Of the 86(N) patients, 75% were males. 40% were aged
0-39 years. Pulmonary TB (PTB) was the commonest type (54%).
ajor extra-pulmonary TB (EPTB) was TB-lymph nodes (33%). Suc-
essful TB (82%) treatment-outcome consisted cured & treatment
ompleted. Unsuccessful outcome (18%) comprised mortality dur-
ng treatment (11%), failures (1%), defaulters &multi-drug resistant
B (1%).
Outcome was signiﬁcantly worse among PTB compared to EPTB
p= 0.001). All deaths (10) were among PTB. HIV infection for more
han 4 years was signiﬁcantly associated with worse outcome (p=
.038). In-spite of better outcomes among those who took ART
89%) compared to those who did not (77%), there was no statis-
ically signiﬁcant difference
Conclusion:The success rateof TB treatment amongco-infected
n this study is similar to other studies in this region. The factors
hichwere signiﬁcantly associatedwith adverse TB treatment out-
omes were type of TB and duration of HIV infection.
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IS6110-PCR is highly sensitive and speciﬁc for conﬁrmation of
differential diagnosis of tuberculosis (TB) in parafﬁn embedded
tissues (PET)
S. Montenegro1,∗, C. Delgado2, S. Pineda3, T. De La Barra4, C.
Reyes4, C. Cabezas4, F. Mucientes2
1 Universidad de Concepcion, Facultad de Medicina, Region del Bio Bio,
Chile
2 Universidad de Concepcion, Concepcion, Chile
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Background: The molecular conﬁrmation of TB is important for
the differential diagnosis of granulomatous inﬂammation in PET
tissues, that occur in various conditions and diseases other than
TB. We investigated the relationship between the histopathologic
features of granulomatous inﬂammationwith the results of TB-PCR
and AFB staining.
Methods: We studied 350 PET samples 1-6 yr old (126 lymph
nodes, 43 skin, 30 lung, 22 pleura, 16 intestine, 13 breast and 100
others tissues: bone, brain, kidney, bone marrow, prostate, larynx,
heart, among others), submitted for the histopathologic diagnosis
of TB.
Histologic Groups.Five histologic groups were deﬁned, accord-
ing to granulomatous inﬂammation ﬁndings:1.Granuloma with
caseous necrosis (n =165); 2.Granuloma without caseous necrosis
(n =50); 3.Granuloma tuberculoid-sarcoidal (n =31);4. Suppurative
granuloma (n=33); 5.Chronic nonspeciﬁc inﬂammation and/or for-
eign body granuloma (n=71).A groupof 20 PETwithout lesionswas
included.
PET Processing.Sections of 5m of identiﬁed lesion were
deparafﬁnized, digested and DNAs extracted following standard
procedure. Only samples with ampliﬁable DNA were included for
analysis.
Nested IS6110 PCR. Outer and inner primers were used to
amplify a 123bp segment of IS6110 insertion sequence of MTB
complex genome.
Results: Absolute sensitivities of PCR versus AFB staining for
MTB for archival PET were: Group 1.Granuloma with caseous
necrosis, PCR 74%, AFB staining 20%. Group2.Granuloma with-
out caseous necrosis, PCR 44%, AFB 9%. Group3. Granuloma
tuberculoid-sarcoidal, PCR 5.%, AFB staining 0%. Group 4. Sup-
purative granuloma, PCR 5%, AFB staining 5%. Group5. Chronic
nonspeciﬁc inﬂammation and/or foreign body granuloma, PCR 2%,
AFB staining 0%. Clinical validity for PCRwas estimated considering
as most probable TB those PET with caseous necrosis granulo-
mas and any positive for AFB staining. IS6110-PCR had: sensitivity
78.4%, speciﬁcity 88% PPV 88.3% and NPV 78%. AFB staining had:
sensitivity 56%, speciﬁcity and PPV 100% and NPV 55%logical diagnoses associated with granulomatous tissue response.
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